Fund comparison

First Pharma Fund versus Magnify CERES II

Fund onevsFund two

Magnify CERES II

Magnify Capital Partners

Private EquityOpen

Residency permit & citizenship vs lock-up

Golden Visa applicants must keep the qualifying €500,000 invested while the residency is active; naturalization timelines vary by case. Not legal advice.

Key facts, side by side

3 of 12 differ · marks a difference

First Pharma FundMagnify CERES II

Minimum investment

€100k

Management fee p.a.

—

2.5%

Performance fee

—

40%

Hurdle rate

20%

Subscription fee

—

Redemption fee

—

~0%

Lock-up

~8 years

5 years

Redemption

At end of term

Fund term

8 years

12 years

Target return

~6.5%+

Not disclosed

Fund size

€16M

—

Inception

—

May 20, 2024

What the fees add up to

At least one of these funds has not published its management fee, so a like-for-like cost projection would be guesswork — we don't draw charts from missing data.

For US investors

Accepted
Unconfirmed
PFIC
PFIC expected, no QEF reporting confirmed
QEF statements
Unconfirmed
IRA route
Unconfirmed

Accepted
Accepts US investors
PFIC
PFIC expected, no QEF reporting confirmed
QEF statements
Unconfirmed
IRA route
Unconfirmed

Research coverage

58%

data completeness

0 fund documents linked · 5 sources cited

Full profile & sources →

85%

data completeness

4 fund documents linked · 7 sources cited

Full profile & sources →

This comparison restates researched data side by side — it is not a recommendation of either fund. Facts marked with a dash or "not disclosed" were not published; how much weight any difference deserves depends on your situation.